John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Fortive
FTV
$18.1B
| $36.6M | 0.11% |
796,326
+628,104
| +373% | +$31.1M |
|
|
SIX
227
DELISTED
Six Flags Entertainment Corp.
SIX
| $36.4M | 0.11% |
835,628
-103,450
| -11% | -$4.36M |
|
|
NVEI
228
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $36.3M | 0.11% |
481,000
-128,900
| -21% | -$7.89M |
|
229
Perrigo
PRGO
$1.98B
| $36M | 0.11% |
936,738
+678,692
| +263% | +$25.8M |
|
230
Plains GP Holdings
PAGP
$5.31B
| $35.8M | 0.11% |
3,100,022
+1,462,790
| +89% | +$16.8M |
|
|
GFLU
231
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $35.5M | 0.1% |
+479,654
| New | +$34.5M |
|
232
iShares Biotechnology ETF
IBB
$10.7B
| $35.5M | 0.1% |
272,501
-267,506
| -50% | -$34.8M |
|
233
Lennar Class A
LEN
$21B
| $35.4M | 0.1% |
450,373
+430,023
| +2,113% | +$38.7M |
|
|
HR
234
DELISTED
Healthcare Realty Trust Incorporated
HR
| $35.2M | 0.1% |
+1,279,414
| New | +$37.7M |
|
235
C3.ai
AI
$1.6B
| $35.1M | 0.1% |
1,547,868
-531,006
| -26% | -$12.8M |
|
236
Elanco Animal Health
ELAN
$12B
| $35.1M | 0.1% |
1,346,442
+791,875
| +143% | +$21.1M |
|
237
WIX.com
WIX
$3.43B
| $35.1M | 0.1% |
336,268
+53,928
| +19% | +$5.89M |
|
238
HubSpot
HUBS
$12B
| $35M | 0.1% |
73,762
-124,632
| -63% | -$60.4M |
|
239
CrowdStrike
CRWD
$195B
| $34.8M | 0.1% |
613,748
-158,028
| -20% | -$7.36M |
|
240
Dave & Buster's
PLAY
$357M
| $34.8M | 0.1% |
708,611
+623,034
| +728% | +$24.9M |
|
241
XPeng
XPEV
$11.7B
| $34.8M | 0.1% |
+1,260,017
| New | +$44.7M |
|
242
Intellia Therapeutics
NTLA
$1.8B
| $34.8M | 0.1% |
478,253
+280,092
| +141% | +$23.7M |
|
243
DaVita
DVA
$11.1B
| $34.7M | 0.1% |
307,052
+125,399
| +69% | +$14.1M |
|
244
ArcelorMittal
MT
$54.4B
| $34.6M | 0.1% |
1,079,689
+655,198
| +154% | +$21M |
|
245
Allstate
ALL
$64.2B
| $34.5M | 0.1% |
249,322
+58,857
| +31% | +$7.39M |
|
246
Neurocrine Biosciences
NBIX
$15.5B
| $34.4M | 0.1% |
366,563
+199,448
| +119% | +$16.9M |
|
247
APA Corp
APA
$15.2B
| $34.2M | 0.1% |
827,606
-1,550,000
| -65% | -$54.1M |
|
|
BRSL
248
Brightstar Lottery PLC
BRSL
$2.21B
| $34.2M | 0.1% |
1,385,503
-1,073,481
| -44% | -$28.8M |
|
249
Vanguard Dividend Appreciation ETF
VIG
$114B
| $34M | 0.1% |
209,503
-416,500
| -67% | -$67.2M |
|
250
Starbucks
SBUX
$122B
| $33.5M | 0.1% |
367,854
-983,558
| -73% | -$92.8M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.